Medical Clinic · Pratumnak Hill, Pattaya
★★★★★ 5.0 · 47 Google reviews · Walk-in clinic · Pratumnak Hill
Educational information. HGH Fragment is not offered as a product for healthy adults or normal aging. Any therapy is individualized, physician-supervised and reserved for appropriate medical indications. Always consult a doctor.
HGH Fragment 176-191 (also called AOD-9604) is the C-terminal tail of the growth-hormone molecule, isolated to study its lipolytic effect. We’ll be honest up front: while a fat-mobilizing effect was shown in the lab, its large human obesity trials did not succeed and it is not a proven weight-loss treatment. At our Peptide Department walk-in clinic on Pratumnak Hill, Pattaya, we provide it only as a physician-supervised, prescription-only research-peptide — physician-supervised and evidence-based, with no fat-loss promises. Ask us for an honest review via WhatsApp.
Dedicated Department
Peptide Department with its own protocols and follow-up structure.
Pharmacy-Verified
Compounded under licensed Bangkok pharmacy, COA-certified.
Evidence-Based
Every claim on this page links to its primary research source.
Lab-Verified
Every batch prepared by a licensed Thai compounding pharmacy with documentation.
Walk-in clinic · Pattaya
In person or online
Real doctor time, your way
Visit our Pattaya clinic in person, or book an online consultation from anywhere in Thailand — the same physician-led care either way.
Serving all Pattaya
Central Pattaya to Jomtien & Chonburi
In-person patients come to us from Central Pattaya, Jomtien, Naklua, Pratumnak and across greater Chonburi — and we consult online nationwide.
For travellers
Travel certificate available
Travelling with a prescribed therapy? We can provide a medical certificate to support your journey.
No referral needed. Visit our Pattaya clinic for a consultation and an honest, physician-led assessment. HGH Fragment at TRT Bangkok is provided through a dedicated Peptide Department with its own protocols, communication system and follow-up structure.
Outside Pattaya?
Not in Pattaya? Book an online consultation with our medical team — same honest, physician-led guidance, just remote.
Book an online consultation →The Science
HGH Fragment 176-191 (also called AOD-9604) is the C-terminal tail of the growth-hormone molecule. In laboratory research it showed a lipolytic (fat-mobilizing) effect — but, importantly, its large human trials for weight loss did not succeed, and we present it on those honest terms.
Mechanism 1
C-terminal GH fragment
It is the 176-191 tail of growth hormone, isolated to study the lipolytic part of the molecule without the full metabolic action of GH itself.
Mechanism 2
Lipolysis via β3-adrenergic pathway
In mice, its lipid-metabolism effect required an intact beta-3 adrenergic receptor — the effect disappeared in beta-3-AR knockout animals (Heffernan et al., Endocrinology, 2001 · PMID 11713213).
Mechanism 3
Human trials: did not succeed
Across roughly 900 participants in Phase I/II trials, the pivotal Phase IIb obesity study did not meet its primary efficacy endpoint and the obesity program was discontinued in 2007 — the lab effect did not translate into meaningful human weight loss.
We will be plain: HGH Fragment is not a proven weight-loss treatment. It is not an approved medicine, and its human efficacy for fat loss was not established. We provide it only as an eligibility-reviewed, physician-supervised research-peptide — not as a fat-loss product.
Every claim above — including the honest one about the failed trials — is drawn from the published record.
What the research shows
The honest picture: a real lipolytic effect in the lab, a clear mechanism, but human weight-loss trials that did not deliver. We think you deserve that context up front.
Lab
Lipolysis signal
A documented fat-mobilizing effect in preclinical models via the beta-3-adrenergic pathway.
Human
Not proven for weight loss
The pivotal obesity trial missed its endpoint; the drug-development program was discontinued.
Access
Physician-supervised, on prescription
Eligibility review first; no self-administration and no published fixed dose — and no fat-loss promises.
If your goal is metabolic weight management, our GLP-1 programs have the strong human evidence — ask and we’ll point you to the right option.
Regulatory status & safety
Approval status
Is HGH Fragment an approved medicine?
HGH Fragment 176-191 is a modified fragment of the growth-hormone molecule studied for fat metabolism. It is not an approved medicine, human evidence is limited, and any use is off-label and should be supervised.
A key caution
Who should be careful
Human data are limited; the main considerations are injection-site reactions and the fact that marketing claims often outrun the evidence — which is exactly why an honest medical read matters before considering it.
Generally not appropriate in: pregnancy, active cancer, unrealistic fat-loss expectations without lifestyle basics.
What a clinician monitors
Sensible checks before & during use
Honest about side effects
Possible side effects
This is why HGH Fragment belongs in a physician-led conversation, not an off-the-shelf purchase — honest risk disclosure and the right monitoring are part of using it responsibly.
Medically reviewed by the TRT Bangkok Peptide Department · a licensed medical clinic in Pattaya, Thailand. Last reviewed August 2026. Every clinical claim on this page links to its primary research source.
Compare the options
How HGH Fragment sits next to the other growth-hormone and secretagogue options — so you can see, honestly, what differs. None of this is a dosing recommendation.
| Peptide | Class | Pattern / half-life | Studied for | Approval |
|---|---|---|---|---|
| HGH (somatropin) | Recombinant growth hormone | Direct GH; steady levels | Diagnosed GH deficiency | Rx medicine (specific indications) |
| Tesamorelin | GHRH analogue | Stimulates own GH; pulsatile | Visceral fat (HIV-lipodystrophy) | FDA-approved (one indication) |
| CJC-1295 (no DAC / with DAC) | GHRH analogue | ~30 min pulsatile / days sustained | Own-GH support (research) | Not approved |
| Ipamorelin | GHRP (secretagogue) | Short, pulsatile GH release | Own-GH support (research) | Not approved |
| HGH Fragment 176-191 | GH fragment | Targets fat metabolism | Lipolysis (research) | Not approved |
Which (if any) is appropriate depends on your goal, your history and your labs — that’s the conversation to have with a doctor, not a decision to make from a table.
Quality & sourcing
This is one of the most overlooked parts of peptide safety. Much of what is sold online as “research” peptide is unregulated, and quality varies enormously. When something is going into a body, the source is not a detail — it is the whole point.
Identity & purity
Is it actually the peptide claimed, at the stated concentration — or under-dosed, mislabeled, or something else entirely?
Sterility
Was it produced and handled under conditions that are actually safe for injection?
Endotoxin contamination
Bacterial byproducts that can trigger fever and inflammatory reactions.
Heavy metals & impurities
Contaminants that have no place in anything you put into your body.
Storage & handling
Many peptides are fragile and temperature-sensitive; poor storage or shipping can degrade a product long before it is used.
Our position
If anything is ever appropriate for you, it is handled to medical standards from a quality-controlled source — and that decision is made with a doctor, not a checkout.
The safest way to answer “where should this come from?” is to bring the question to a clinician. We’re happy to talk it through — honestly, with no pressure.
How it works at our clinic
This is an educational page, not a checkout. We don’t sell HGH Fragment off the shelf. If it is clinically appropriate for you, any use is individualized and physician-supervised — here’s the path.
1
Understand the science
We explain what HGH Fragment does — and what the human evidence does and does not support — in plain language, with every claim linked to its source.
2
Consultation & assessment
A medical review of your goals and history — and, where relevant, testing. A doctor decides suitability, and will say so honestly if a better-evidenced option fits.
3
Supervised, if appropriate
Only if suitable: a protocol set individually and monitored. Prescription-only, no published one-size dosing, first administration guided at our Pattaya clinic.
There is no public price and no “order” button, by design: HGH Fragment is a medical matter, handled through consultation at a real, licensed Pattaya clinic.
Patient Reviews
from 48 verified Google reviews
Patients who choose our Peptide Department for HGH Fragment get honesty, not hype — a physician review and the real evidence, including its failed weight-loss trials. Every vial is physician-supervised and grounded in the evidence; these ratings come live from our Google Business Profile and are refreshed regularly.
Verified patients
Real Google reviews
Updated regularly
Straight from our profile
Walk-in clinic
Pratumnak Hill, Pattaya
The research behind HGH Fragment
This is a case where we lead with the honest conclusion: a genuine preclinical mechanism, but human weight-loss trials that did not succeed. Both belong on the page.
Preclinical mechanism
Heffernan MA, et al. Endocrinology, 2001 · PMID 11713213
Showed AOD-9604 (HGH Fragment 176-191) reduced body fat in obese mice and that its lipid effect required the beta-3-adrenergic receptor. A real, mechanistic lab finding. PubMed
Human trials · honest
Phase IIb obesity trial · missed endpoint (2007)
Across ~900 participants in Phase I/II studies, the pivotal Phase IIb obesity trial did not meet its primary efficacy endpoint and the obesity program was discontinued. The lab effect did not translate to meaningful human weight loss.
Evidence status
Not an approved medicine
HGH Fragment is not FDA-approved and is not proven for fat loss. We provide it only as an eligibility-reviewed, physician-supervised research-peptide — with no fat-loss claims.
Better-evidenced route
For weight: GLP-1 programs
If the goal is metabolic weight management, the strong human evidence is in GLP-1 therapies — we’ll point you there rather than overselling a fragment.
Where a peer-reviewed source exists, it is linked above; the trial outcome is drawn from the published development record.
Frequently Asked
Not on the human evidence. A lipolytic effect was shown in the lab, but the pivotal human obesity trial did not meet its endpoint and the program was discontinued. We do not market it as a fat-loss treatment.
It is the C-terminal 176-191 tail of the growth-hormone molecule, isolated to study the lipolytic part of GH. It is a research-peptide, not an approved medicine.
Because patients ask about it — and we’d rather give you the honest evidence and a physician review than let you buy it unsupervised online. If a better-evidenced option fits your goal, we’ll say so.
Prescription-only subcutaneous injection, individualized after a physician review. We don’t publish fixed dosing; your first injection is demonstrated at our Pattaya clinic. Always consult a doctor.
The strong human evidence for weight management is in GLP-1 therapies. Ask us and we’ll point you to the right, evidence-based option rather than overselling a fragment.
Yes. Every vial is prepared through a licensed Thai compounding pharmacy ,. Explore more on our peptide therapy hub.
How We Verify · Where To Find Us
Product is prepared by our licensed compounding pharmacy to medical standards — verified at the point of dispense, not from an anonymous online seller.
Licensed medical facility
License No. 72509 · Chon Buri, Thailand. Open Monday–Saturday, 8:00 am – 6:00 pm.
★★★★★ 5.0 from 47 verified Google reviews · Read them on Google
389/203 Moo 12, Bang Lamung, Pattaya, Chon Buri 20150 · +66 84 224 9559
Our Peptide Department covers the full clinical-research spectrum — recovery, growth-hormone support, skin and longevity, libido and visceral fat.
HGH Fragment at TRT Bangkok is provided through a dedicated Peptide Department under the TRT Bangkok umbrella. This department has its own protocols, communication system and follow-up structure. Compounded under licensed Bangkok pharmacy · independent peptide protocols · eligibility-reviewed. All claims subject to current Thai regulations · individual eligibility. References available on request. Not for use during pregnancy. Individual results vary.
HGH Fragment 176-191 is a modified section of the growth hormone molecule — specifically the tail end of the amino-acid chain. The idea behind it in research is that this fragment may relate to fat metabolism while leaving aside other actions of the full hormone. It is a research peptide, and much of the interest around it comes from laboratory work rather than from large, settled clinical studies.
Because it is investigational rather than an approved medicine, honest framing matters. HGH Fragment is not a weight-loss supplement, not something with guaranteed outcomes, and not a product to self-dose. In a responsible setting it is handled only after an eligibility review, with expectations kept realistic.
In Pattaya, the theme that comes up most is verification. Fragments and modified peptides are easy to mislabel, and the grey market rarely provides any proof of what a vial actually contains. Material whose identity and purity have been checked by methods such as HPLC and mass spectrometry, and which is kept in a 2–8 °C cold chain, gives a level of confidence that an anonymous online purchase simply cannot. Once reconstituted, the peptide is also fragile and time-sensitive, which is easier to manage through a local, controlled supply.
Our Pattaya clinic on Pratumnak Hill is there so the real questions — what the research shows, how the material is verified, and how eligibility is reviewed — can be answered in person or over WhatsApp. Nothing here is medical advice, and no protocol begins without an appropriate eligibility check. The aim is an accurate, grounded starting point for understanding HGH Fragment 176-191 locally.
Ready to start HGH Fragment in Pattaya?
